Report cover image

Urinary Tract Infection Treatment Market, By Drug Type (Penicillin & Combinations (Amoxicillin, "Amoxicillin+ Clavulanate, Potassium", Others)), Quinolones (Ciprofloxacin, Levofloxacin, Nalidixic acid, Norfloxacin, Others), Cephalosporin (Ceftriaxone, Cef

Publisher Coherent Market Insights
Published May 11, 2022
Length 197 Pages
SKU # CMI17212558

Description

Urinary Tract Infection Treatment Market, By Drug Type (Penicillin & Combinations (Amoxicillin, "Amoxicillin+ Clavulanate, Potassium", Others)), Quinolones (Ciprofloxacin, Levofloxacin, Nalidixic acid, Norfloxacin, Others), Cephalosporin (Ceftriaxone, Cefuroxime, Cefixime, Cephalexin), Aminoglycoside Antibiotics (Amikacin, Gentamicin), "Sulphonamides (Sulfamethoxazole +, Trimethoprim)", Azoles and Amphotericin B, Tetracycline (Doxycycline), Nitrofurans (Nitrofurantoin), Other), By Disease Indication (Complicated UTI, Recurring Complicated UTI, Uncomplicated UTI, Neurogenic Bladder Infections), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Urinary Tract Infection (UTI) is caused when bacteria enters the urethra and infects the urinary bladder, causing severe health issues. UTI infections are common health problems in females than in males with biologic factors accounting as the major cause. Antibiotics are usually the first line of treatment prescribed by doctors for urinary tract infections. According to the site of manifestation by the microbe, infections are classified as cystitis (bladder), urethritis (urethra), prostatitis (prostate) or pyelonephritis (kidney). Painful and increased frequency of urination, excessive and involuntary passing of urine at night are the common symptoms associated with UTI. Hospitalized patients using urinary catheters are at a higher risk for developing UTI.
Restraints of the Global Urinary Tract Infection Treatment Market
Major factors hampering the growth of the urinary tract infection treatment market during the forecast period constitutes of low adoption of internet in some emerging economies.
Key features of the study:
This report provides in-depth analysis of the global urinary tract infection treatment market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global urinary tract infection treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Cipla Ltd., Johnson & Johnson, Bayer AG, Pfizer Inc., GlaxoSmithKline, Boehringer Ingelheim, F. Hoffmann-La Roche Ltd., Iterum Therapeutics plc, Novartis AG AstraZeneca Plc, Allecra Therapeutics, Healthy.io, Shionogi Inc., Spero Therapeutics, Inc., and Venatorx Pharmaceuticals.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global urinary tract infection treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Urinary Tract Infection Treatment Market, By Drug Type:
Penicillin & Combinations
Amoxicillin"Amoxicillin+ Clavulanate
Potassium"
Others
Quinolones
Ciprofloxacin
Levofloxacin
Nalidixic acid
Norfloxacin
Others
Cephalosporin
Ceftriaxone
Cefuroxime
Cefixime
Cephalexin
Aminoglycoside Antibiotics
Amikacin
Gentamicin"Sulphonamides (Sulfamethoxazole +
Trimethoprim)"
Azoles and Amphotericin B
Tetracycline (Doxycycline)
Nitrofurans (Nitrofurantoin)
Other
Global Urinary Tract Infection Treatment Market, By Disease Indication:
Complicated UTI
Recurring Complicated UTI
Uncomplicated UTI
Neurogenic Bladder Infections
Global Urinary Tract Infection Treatment Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Urinary Tract Infection Treatment Market, By Geography:
North America
By Drug Type
Penicillin & Combinations
Amoxicillin
"Amoxicillin+ Clavulanate
Potassium"
Others
Quinolones
Ciprofloxacin
Levofloxacin
Nalidixic acid
Norfloxacin
Others
Cephalosporin
Ceftriaxone
Cefuroxime
Cefixime
Cephalexin
Aminoglycoside Antibiotics
Amikacin
Gentamicin"Sulphonamides (Sulfamethoxazole +
Trimethoprim)"
Azoles and Amphotericin B
Tetracycline (Doxycycline)
Nitrofurans (Nitrofurantoin)
Other
By Disease Indication
Complicated UTI
Recurring Complicated UTI
Uncomplicated UTI
Neurogenic Bladder Infections
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Europe
By Drug Type
Penicillin & Combinations
Amoxicillin
"Amoxicillin+ Clavulanate
Potassium"
Others
Quinolones
Ciprofloxacin
Levofloxacin
Nalidixic acid
Norfloxacin
Others
Cephalosporin
Ceftriaxone
Cefuroxime
Cefixime
Cephalexin
Aminoglycoside Antibiotics
Amikacin
Gentamicin"Sulphonamides (Sulfamethoxazole +
Trimethoprim)"
Azoles and Amphotericin B
Tetracycline (Doxycycline)
Nitrofurans (Nitrofurantoin)
Other
By Disease Indication
Complicated UTI
Recurring Complicated UTI
Uncomplicated UTI
Neurogenic Bladder Infections
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Drug Type
Penicillin & Combinations
Amoxicillin
"Amoxicillin+ Clavulanate
Potassium"
Others
Quinolones
Ciprofloxacin
Levofloxacin
Nalidixic acid
Norfloxacin
Others
Cephalosporin
Ceftriaxone
Cefuroxime
Cefixime
Cephalexin
Aminoglycoside Antibiotics
Amikacin
Gentamicin"Sulphonamides (Sulfamethoxazole +
Trimethoprim)"
Azoles and Amphotericin B
Tetracycline (Doxycycline)
Nitrofurans (Nitrofurantoin)
Other
By Disease Indication
Complicated UTI
Recurring Complicated UTI
Uncomplicated UTI
Neurogenic Bladder Infections
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Drug Type
Penicillin & Combinations
Amoxicillin
"Amoxicillin+ Clavulanate
Potassium"
Others
Quinolones
Ciprofloxacin
Levofloxacin
Nalidixic acid
Norfloxacin
Others
Cephalosporin
Ceftriaxone
Cefuroxime
Cefixime
Cephalexin
Aminoglycoside Antibiotics
Amikacin
Gentamicin"Sulphonamides (Sulfamethoxazole +
Trimethoprim)"
Azoles and Amphotericin B
Tetracycline (Doxycycline)
Nitrofurans (Nitrofurantoin)
Other
By Disease Indication
Complicated UTI
Recurring Complicated UTI
Uncomplicated UTI
Neurogenic Bladder Infections
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Drug Type
Penicillin & Combinations
Amoxicillin
"Amoxicillin+ Clavulanate
Potassium"
Others
Quinolones
Ciprofloxacin
Levofloxacin
Nalidixic acid
Norfloxacin
Others
Cephalosporin
Ceftriaxone
Cefuroxime
Cefixime
Cephalexin
Aminoglycoside Antibiotics
Amikacin
Gentamicin"Sulphonamides (Sulfamethoxazole +
Trimethoprim)"
Azoles and Amphotericin B
Tetracycline (Doxycycline)
Nitrofurans (Nitrofurantoin)
Other
By Disease Indication
Complicated UTI
Recurring Complicated UTI
Uncomplicated UTI
Neurogenic Bladder Infections
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Drug Type
Penicillin & Combinations
Amoxicillin
"Amoxicillin+ Clavulanate
Potassium"
Others
Quinolones
Ciprofloxacin
Levofloxacin
Nalidixic acid
Norfloxacin
Others
Cephalosporin
Ceftriaxone
Cefuroxime
Cefixime
Cephalexin
Aminoglycoside Antibiotics
Amikacin
Gentamicin"Sulphonamides (Sulfamethoxazole +
Trimethoprim)"
Azoles and Amphotericin B
Tetracycline (Doxycycline)
Nitrofurans (Nitrofurantoin)
Other
By Disease Indication
Complicated UTI
Recurring Complicated UTI
Uncomplicated UTI
Neurogenic Bladder Infections
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Cipla Ltd.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Johnson & Johnson
Bayer AG
Pfizer Inc.
GlaxoSmithKline
Boehringer Ingelheim
F. Hoffmann-La Roche Ltd.
Iterum Therapeutics plc
Novartis AG
AstraZeneca Plc
Allecra Therapeutics
Shionogi Inc.
Spero Therapeutics, Inc.
Venatorx Pharmaceuticals.
“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

197 Pages
1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Disease Indication
Market Snippet, By Distribution Channel
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
Regulatory Scenario
PEST Analysis
COVID-19 Impact Analysis
4. Global Urinary Tract Infection Treatment Market, By Drug Type, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Penicillin & Combinations
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Amoxicillin
Amoxicillin+ Clavulanate
Potassium
"
Others
Quinolones
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Ciprofloxacin
Levofloxacin
Nalidixic acid
Norfloxacin
Others
Cephalosporin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Ceftriaxone
Cefuroxime
Cefixime
Cephalexin
Aminoglycoside Antibiotics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Amikacin
Gentamicin
"Sulphonamides (Sulfamethoxazole +
Trimethoprim)
"
Azoles and Amphotericin B
Tetracycline (Doxycycline)
Nitrofurans (Nitrofurantoin)
Other
5. Global Urinary Tract Infection Treatment Market, By Disease Indication, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Complicated UTI
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Recurring Complicated UTI
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Uncomplicated UTI
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Neurogenic Bladder Infections
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
6. Global Urinary Tract Infection Treatment Market, By Distribution Channel, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
7. Global Urinary Tract Infection Treatment Market, By Regions, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
North Africa
Central Africa
South Africa
8. Competitive Landscape
Company Profiles
Cipla Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Johnson & Johnson
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Bayer AG
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
GlaxoSmithKline
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Boehringer Ingelheim
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
F. Hoffmann-La Roche Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Iterum Therapeutics plc
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis AG
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
AstraZeneca Plc
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Allecra Therapeutics
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Shionogi Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Spero Therapeutics, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Venatorx Pharmaceuticals.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 37 market data tables and 26 figures on “Urinary Tract Infection Treatment Market – Global forecast to 2028.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us